Pediatric obstructive sleep apnoea remains under-diagnosed relative to its prevalence. The condition is recognised, the consequences are well-documented, and the treatment options are reasonable. The bottleneck is the evaluation pathway — getting children with concerning symptoms through screening, formal evaluation, and onto appropriate management. The pathway in May 2026 has continued to evolve and the practice variation is wider than it should be.

This is a working clinical view focused on where the pathway sits and what’s working in different settings.

The screening question

The screening for paediatric OSA in primary care continues to be inconsistent. Some primary care services screen actively and refer appropriately. Others miss the symptoms or attribute them to other causes.

The symptom triad of habitual snoring, observed apnoea, and disrupted sleep architecture is reasonably specific when present. The challenge is that parents don’t always volunteer the information unprompted. The questions have to be asked. Primary care services that have built systematic screening into well-child visits identify more cases. Services that rely on parents to raise the issue identify fewer.

The screening tools that work well are short, validated, and easy to integrate into primary care. The longer questionnaires that capture more nuance often don’t get used because they take too long. The shorter screening forms have been the more successful approach in primary care implementation.

The referral pathway

Once concern is raised, the pathway to formal evaluation varies substantially across the country. In well-resourced metropolitan areas, the pathway from primary care concern to a sleep medicine specialist or paediatric ENT appointment can be a few weeks. In other regions, the pathway can be months.

The wait time matters because the consequences of untreated paediatric OSA include effects on neurocognitive development, growth, and behaviour that don’t pause while waiting for an appointment. A child waiting six months for a sleep evaluation is six months further into the developmental window where the consequences accumulate.

Services that have invested in shorter pathways — telehealth-supported initial reviews, clear referral criteria, allocated diagnostic capacity — produce better outcomes than services that haven’t. The investment is real but the case for it is strong.

The diagnostic options

The diagnostic options for paediatric OSA include in-laboratory polysomnography, home sleep study (with caveats), and clinical evaluation supplemented by physical examination findings.

In-laboratory polysomnography remains the gold standard. The test is more demanding for children than for adults — the unfamiliar environment, the wires, the staff, the disruption of normal sleep. Skilled paediatric sleep laboratories handle this well. Less specialised laboratories sometimes don’t.

Home sleep study has expanded in paediatric use but with appropriate caution. The signal quality from home studies in younger children is variable. The interpretation requires more clinical judgement than in adults. For older children with classic symptoms, home study can be a reasonable alternative to laboratory study. For younger children or for cases with diagnostic uncertainty, the laboratory study remains preferable.

Clinical evaluation supplemented by physical examination — particularly identification of significant tonsillar enlargement — can sometimes be the operating diagnostic basis when formal sleep studies aren’t accessible. This is suboptimal but in some service contexts it’s the realistic alternative to no evaluation at all.

The 2026 picture is that the choice of diagnostic approach should be matched to the specific child’s situation and the local service capability. Inflexible insistence on a single approach across all cases produces worse outcomes than thoughtful matching.

The treatment landscape

Adenotonsillectomy remains the first-line treatment for most children with significant OSA and the appropriate anatomical findings. The evidence base supporting this is robust. The outcomes are typically excellent in well-selected cases.

The post-surgical follow-up is the area where practice variation has been notable. Some services follow children carefully post-operatively to verify resolution. Others discharge after the initial surgical follow-up. The careful follow-up identifies the meaningful minority of children with persistent OSA after surgery and gets them onto appropriate further management. The early discharge model misses these children, who then resurface months or years later with continuing symptoms.

For children with persistent OSA after surgery, or for whom surgery isn’t the appropriate first option, the further management options include CPAP, orthodontic intervention where appropriate, and weight management where relevant. CPAP in children is a separate clinical challenge with its own learning curve for clinicians and families.

The behavioural and developmental dimension

The clinical assessment of paediatric OSA has increasingly integrated the behavioural and developmental picture. Children present with attention issues, behavioural concerns, and learning difficulties that may have OSA as a contributor. The diagnostic challenge is that these symptoms are non-specific and have many other potential causes.

The pattern that’s worked clinically is to include sleep evaluation in the diagnostic work-up for children presenting with attention or behavioural concerns, particularly where there are sleep-related symptoms. The sleep evaluation isn’t always the answer but when it is, treating the OSA can substantially improve the behavioural picture.

The conversation with families about this connection is sometimes delicate. Families who have been pursuing behavioural diagnoses can be both relieved and frustrated to find that a sleep issue may have been a contributor.

The service capacity question

The structural issue across paediatric sleep services is capacity. The demand exceeds the supply in most regions, and the supply has been growing slower than the recognition of paediatric OSA has grown.

Services that have managed this well have done so through efficient triage, appropriate use of telehealth for clinical review, and clear pathways for the cases that need specialist input versus the cases that can be managed in primary care or general paediatrics.

Services that haven’t managed it well have ended up with long waits and uneven access. The children with the most articulate parents, in the regions with the most resourced services, get evaluated. The children without those advantages don’t.

The structural inequity isn’t unique to paediatric sleep services. It’s a familiar pattern across paediatric specialty services. The remediation has to be system-level rather than clinic-level.

Where this goes

The paediatric OSA evaluation pathway will continue to evolve through 2026 and beyond. The directions of change are reasonably clear.

Better integration with primary care screening. Continued expansion of telehealth-supported evaluation. Continued careful evaluation of where home sleep study is appropriate in children. Continued investment in service capacity, though probably not at the pace that demand requires.

The clinical lesson for practitioners is to maintain awareness of paediatric OSA in the differential for children with appropriate symptoms, to refer thoughtfully, and to follow up diligently after treatment. The patients best served by the current pathway are the ones whose clinicians take the condition seriously and pursue it.